<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T15:42:00Z</responseDate>
  <request identifier="oai:figshare.com:article/34010817" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34010817</identifier>
        <datestamp>2026-09-28T08:13:13Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Single-cell landscape of lymphoid and myeloid heterogeneity across type-stratified craniofacial lesions in polyostotic fibrous dysplasia.pdf</dc:title>
          <dc:creator>Hui-Chuan Duan (25120893)</dc:creator>
          <dc:creator>Xia Liang (179535)</dc:creator>
          <dc:creator>De-Cheng Wang (15867163)</dc:creator>
          <dc:creator>Jie Yuan (208425)</dc:creator>
          <dc:creator>Fan Yang (1413)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>cell-cell communication</dc:subject>
          <dc:subject>craniofacial lesions</dc:subject>
          <dc:subject>histological subtypes</dc:subject>
          <dc:subject>immune microenvironment</dc:subject>
          <dc:subject>lymphoid cells</dc:subject>
          <dc:subject>myeloid cells</dc:subject>
          <dc:subject>polyostotic fibrous dysplasia</dc:subject>
          <dc:subject>single-cell RNA sequencing</dc:subject>
          <dc:description>Background&lt;p&gt;Polyostotic fibrous dysplasia (POFD) is a mosaic skeletal disorder driven by somatic GNAS mutations that constitutively activate Gsα-cAMP signaling, producing fibro-osseous craniofacial deformities. POFD lesions are histologically classified into three subtypes—Type I (connective-tissue predominant), Type II (cancellous-bone predominant), and Type III (sclerotic-bone predominant)—yet the immune microenvironment across these categories remains undefined. This study aims to dissect lymphoid and myeloid heterogeneity and inter-cellular communication networks among distinct POFD histological categories.&lt;/p&gt;Methods&lt;p&gt;We performed single-cell RNA sequencing on maxillary lesion tissues from three age- and sex-matched POFD patients classified as Type I (n=1), Type II (n=1), and Type III (n=1). After stringent quality control, 24,567 cells (median 1,762 genes/cell) were integrated and clustered. Ligand–receptor interactions were inferred using CellChat.&lt;/p&gt;Results&lt;p&gt;Four major lineages were resolved: mesenchyme, lymphoid, myeloid, endovascular. Lymphoid representation differed across subtypes (Type I 1.00%, Type II 5.10%, Type III 10.90%), whereas endovascular fractions showed an inverse pattern (Type I 25.10%, Type II 9.90%, Type III 4.50%). Sub-clustering identified five lymphoid and six myeloid subsets. CD4&lt;sup&gt;+&lt;/sup&gt; T cells were most abundant in Type I (51.10%) but less represented in Type II (36.50%) and Type III (29.30%). CD8&lt;sup&gt;+&lt;/sup&gt; T cells constituted 2.10%, 11.90%, and 11.20% across Types I-III, respectively; germinal-center (GC) B cells were undetectable in Type I, minor in Type II (~1.60%), and prominent in Type III (~29.20%). Among myeloid cells, M1 macrophages comprised 9.90% in Type I, 25.70% in Type II, and 15.30% in Type III; osteoclasts were abundant in Type I (35.40%) but scarce in Types II and III (&lt;5%). Dendritic cells (DCs) were absent in Type I yet detectable in Type II (1.90%) and Type III (2.60%). Network-central genes included LTB, TXNIP, FTH1, and PABPC1 for CD4&lt;sup&gt;+&lt;/sup&gt; and GC B cells, and S100A8/9, CXCL8, CCL2/3/4, and IL1B for M1 macrophages and monocytes. Inter-cellular communication networks differed markedly by subtype: Type I and II displayed relatively simple interactomes, whereas Type III exhibited densely interconnected signaling with strengthened M2 macrophage-monocyte, M2 macrophage-GC B cell (CXCL12-CXCR4, APP-CD74), and GC B cell-monocyte axes, alongside attenuated CD4&lt;sup&gt;+&lt;/sup&gt; T cell-GC B cell (CLEC2D-KLRB1, ADGRE5-CD55) and M1 macrophage-CD4&lt;sup&gt;+&lt;/sup&gt; T cell crosstalk. Pathway enrichment revealed subtype-specific activation of oxidative phosphorylation, NF-κB, and antigen-presentation cascades across lymphoid and myeloid compartments.&lt;/p&gt;Conclusions&lt;p&gt;This study provides the first single-cell immune atlas of POFD, delineating lymphoid and myeloid heterogeneity across three histological subtypes. The identified subtype-specific markers and inter-cellular communication architectures offer candidate biomarkers for diagnostic stratification and reveal potential immunomodulatory targets for this disfiguring bone disorder.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T08:13:13Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1906418.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Single-cell_landscape_of_lymphoid_and_myeloid_heterogeneity_across_type-stratified_craniofacial_lesions_in_polyostotic_fibrous_dysplasia_pdf/34010817</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
